相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial
Sobha Sivaprasad et al.
LANCET (2017)
The Clinical Importance of Changes in Diabetic Retinopathy Severity Score
Michael S. Ip et al.
OPHTHALMOLOGY (2017)
Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy
Charles C. Wykoff et al.
OPHTHALMOLOGY (2017)
Change in Diabetic Retinopathy Through 2 Years Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab
Susan B. Bressler et al.
JAMA OPHTHALMOLOGY (2017)
The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy
Cecilia S. Lee et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2017)
Ischemic index changes in diabetic retinopathy after intravitreal dexamethasone implant using ultra-widefield fluorescein angiography: a pilot study
Lea Querques et al.
ACTA DIABETOLOGICA (2017)
Local and Systemic Inflammatory Biomarkers of Diabetic Retinopathy: An Integrative Approach
Stela Vujosevic et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
A single-nucleotide polymorphism in the MicroRNA-146a gene is associated with diabetic nephropathy and sight-threatening diabetic retinopathy in Caucasian patients
Georgia Kaidonis et al.
ACTA DIABETOLOGICA (2016)
Effects of the neuroprotective drugs somatostatin and brimonidine on retinal cell models of diabetic retinopathy
Elena Beltramo et al.
ACTA DIABETOLOGICA (2016)
Association between body mass index and diabetic retinopathy in Chinese patients with type 2 diabetes
Jun Lu et al.
ACTA DIABETOLOGICA (2015)
Molecular mechanisms of extracellular vesicle-induced vessel destabilization in diabetic retinopathy
Aurora Mazzeo et al.
ACTA DIABETOLOGICA (2015)
Body mass index and retinopathy in Asian populations with diabetes mellitus
David Rooney et al.
ACTA DIABETOLOGICA (2015)
Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema
David S. Boyer et al.
OPHTHALMOLOGY (2014)
Euglycemic progression: Worsening of diabetic retinopathy in poorly controlled type 2 diabetes in minorities
A. Shurter et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme
H. C. Looker et al.
DIABETOLOGIA (2013)
Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials RISE and RIDE
David M. Brown et al.
OPHTHALMOLOGY (2013)
Exploratory Analysis of the Effect of Intravitreal Ranibizumab or Triamcinolone on Worsening of Diabetic Retinopathy in a Randomized Clinical Trial
Susan B. Bressler et al.
JAMA OPHTHALMOLOGY (2013)
Long-term Effects of Ranibizumab on Diabetic Retinopathy Severity and Progression
Michael S. Ip et al.
ARCHIVES OF OPHTHALMOLOGY (2012)
Role of Intravitreal Inflammatory Cytokines and Angiogenic Factors in Proliferative Diabetic Retinopathy
Jinzi Zhou et al.
CURRENT EYE RESEARCH (2012)
Ranibizumab for Diabetic Macular Edema Results from 2 Phase III Randomized Trials: RISE and RIDE
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2012)
Inflammation in diabetic retinopathy
Johnny Tang et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2011)
Profile of Lipid and Protein Autacoids in Diabetic Vitreous Correlates With the Progression of Diabetic Retinopathy
Michal Laniado Schwartzman et al.
DIABETES (2010)
Exploratory Analysis of Diabetic Retinopathy Progression Through 3 Years in a Randomized Clinical Trial That Compares Intravitreal Triamcinolone Acetonide With Focal/Grid Photocoagulation
Neil M. Bressler et al.
ARCHIVES OF OPHTHALMOLOGY (2009)
Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications
Ronald B. Goldberg
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
Nish Chaturvedi et al.
LANCET (2008)
How corticosteroids control inflammation: Quintiles prize lecture 2005
Peter J. Barnes
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina
H Tamura et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients
H Funatsu et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2005)
分享论文
